Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. 180 Life Sciences Corporation (ATNF)
  7. News

ATNF

180 Life Sciences News

FREE ATNF REPORT

Company Name Stock Ticker Symbol Market Type
180 Life Sciences Corporation ATNF NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
-0.30 -8.29% 3.32 14:47:44
Open Price Low Price High Price Close Price Prev Close
3.67 3.09 3.89 3.62
more quote information »

Recent News

Date Time Source Heading
1/27/202311:59IHNWFeatured1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition
1/25/202308:45GLOBE180 Life Sciences Announces Publication of a Review on the Treatments for Early..
1/18/202316:29EDGARCurrent Report Filing (8-k)
1/17/202308:01EDGARCurrent Report Filing (8-k)
1/17/202308:00GLOBE180 Life Sciences Engages Kinexum for Assistance in Applying..
1/10/202313:56BWNewman Ferrara LLP Investigating Officers and Directors of..
1/05/202309:30EDGARCurrent Report Filing (8-k)
1/05/202308:30GLOBE180 Life Sciences Regains Full Compliance with Nasdaq..
1/04/202308:31EDGARCurrent Report Filing (8-k)
1/04/202308:30GLOBE180 Life Sciences Announces Publication of a Review on the Biological Basis of Dupuytren’s Disease
12/29/202216:31EDGARCurrent Report Filing (8-k)
12/29/202208:31EDGARCurrent Report Filing (8-k)
12/29/202208:30GLOBE180 Life Sciences Corp. CEO James Woody, MD, PhD Issues..
12/23/202208:00GLOBE180 Life Sciences Corp. Announces Closing of $6 Million..
12/22/202217:16EDGARCurrent Report Filing (8-k)
12/20/202214:11GLOBE180 Life Sciences Corp. Announces $6 Million Registered..
12/16/202209:01EDGARCurrent Report Filing (8-k)
12/16/202209:00GLOBE180 Life Sciences Corp. Announces 1-for 20 Reverse Stock..
11/30/202217:00GLOBE180 Life Sciences Provides Update on Progress To Seek..
11/21/202208:30GLOBE180 Life Sciences to Participate in A.G.P.’s Virtual Biotech..
11/16/202208:31EDGARProxy Statement (definitive) (def 14a)
11/15/202212:37GLOBECORRECTION: Adalimumab Found To Be A Likely Cost-Effective..
11/15/202208:00GLOBEAdalimumab Found To Be A Likely Cost-Effective Treatment for..
11/10/202216:27EDGARQuarterly Report (10-q)
11/04/202217:04EDGARProxy Statement - Notice of Shareholders Meeting..
11/02/202217:02EDGARStatement of Changes in Beneficial Ownership (4)
11/02/202217:01EDGARStatement of Changes in Beneficial Ownership (4)
10/04/202208:31EDGARCurrent Report Filing (8-k)
9/26/202208:31EDGARCurrent Report Filing (8-k)
9/26/202208:30GLOBE180 Life Sciences Issues Letter to Stockholders
9/23/202218:15EDGARStatement of Changes in Beneficial Ownership (4)
8/22/202208:32EDGARCurrent Report Filing (8-k)
8/22/202208:30GLOBE180 Life Sciences with the University of Oxford Announce the..
8/09/202217:01EDGARSecurities Registration: Employee Benefit Plan (s-8)
7/29/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
7/27/202208:37EDGARCurrent Report Filing (8-k)
7/27/202208:30GLOBE180 Life Sciences Announces That the University of Oxford..
7/21/202208:00GLOBE180 Life Sciences Corp. Announces Closing of $6.5 Million..
7/19/202216:11EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
7/18/202208:30GLOBE180 Life Sciences Corp. Announces $6.5 Million Registered..
6/24/202216:28EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
6/22/202216:16EDGARCurrent Report Filing (8-k)
6/22/202216:05GLOBE180 Life Sciences Corp. Issues Letter to Stockholders
6/14/202216:16EDGARCurrent Report Filing (8-k)
6/14/202216:15GLOBE180 Life Sciences Provides Update on Correspondence Received..
6/03/202216:38EDGARSecurities Registration Statement (simplified Form) (s-3)
6/03/202216:35EDGARPost-effective Amendment to Registration Statement (pos Am)
5/31/202208:30GLOBE180 Life Sciences Begins Consultations with UK and US..
5/27/202206:25EDGARCurrent Report Filing (8-k)
5/23/202216:34EDGARStatement of Changes in Beneficial Ownership (4)
5/23/202216:34EDGARStatement of Changes in Beneficial Ownership (4)